Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 72 | 3,069−1.3%/yr | −1.3%/yr | 2.90.9× | 0% | 3,830 in 2030+3.8%/yr |
| Decompression & minimally invasive spine | 64 | 2,968−6.1%/yr | −6.1%/yr | 2.80.8× | 2% | 3,270 in 2030+1.7%/yr |
| Kyphoplasty & vertebroplasty | 21 | 1,869−3.9%/yr | −3.9%/yr | 1.81.0× | 28% | 2,170 in 2030+2.6%/yr |
| Cervical fusion & disc arthroplasty | 35 | 1,533−3.6%/yr | −3.6%/yr | 1.40.8× | 1% | 1,680 in 2030+1.6%/yr |
| SI joint fusion | 3 | 167+8.3%/yr | +8.3%/yr | 0.10.4× | 0% | 390 in 2030+15%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 344 | 68,692−0.3%/yr | −0.3%/yr | 63.20.5× | 42% | 87,800 in 2030+4.2%/yr |
| Skin substitutes & wound grafts | 47 | 9,709+14%/yr | +14%/yr | 6.50.6× | 70% | 21,900 in 2030+14%/yr |
| Bone graft & orthobiologics | 17 | 601−14%/yr | −14%/yr | 0.60.8× | 0% | 650 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 121 | 10,959+2.8%/yr | +2.8%/yr | 10.10.7× | 80% | 13,100 in 2030+3%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 13 | 571−0.7%/yr | −0.7%/yr | 0.50.4× | 30% | 670 in 2030+2.7%/yr |
| Spinal cord & DRG stimulation | 13 | 494−4.5%/yr | −4.5%/yr | 0.40.5× | 18% | 600 in 2030+3.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 50 | 5,185−16%/yr | −16%/yr | 5.10.9× | 61% | 5,340 in 2030+0.5%/yr |
| Superficial venous ablation | 57 | 3,844−3.8%/yr | −3.8%/yr | 3.50.6× | 94% | 4,330 in 2030+2%/yr |
| Peripheral arterial intervention | 30 | 3,751−7.6%/yr | −7.6%/yr | 3.50.5× | 43% | 5,530 in 2030+6.7%/yr |
| Carotid revascularization | 28 | 1,070−3.9%/yr | −3.9%/yr | 1.00.8× | 0% | 1,290 in 2030+3.1%/yr |
| Thrombectomy, IVC filters & venous stents | 4 | 1,041−5.6%/yr | −5.6%/yr | 1.00.6× | 2% | 1,720 in 2030+8.7%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 443−6.2%/yr | −6.2%/yr | 0.40.9× | 0% | 440 in 2030−0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 89 | 6,010−2.5%/yr | −2.5%/yr | 6.01.0× | 2% | 6,760 in 2030+2%/yr |
| Cholecystectomy & appendectomy | 74 | 3,844−4.8%/yr | −4.8%/yr | 3.70.8× | 1% | 4,110 in 2030+1.1%/yr |
| Colorectal resection | 8 | 1,510−4.9%/yr | −4.9%/yr | 1.50.9× | 0% | 1,480 in 2030−0.3%/yr |
| Antireflux & hiatal hernia surgery | 10 | 705−0.8%/yr | −0.8%/yr | 0.70.8× | 0% | 920 in 2030+4.6%/yr |
| Breast reconstruction | 3 | 428−9.4%/yr | −9.4%/yr | 0.40.8× | 0% | 410 in 2030−0.8%/yr |
| Bariatric surgery | 0 | 144−13%/yr | −13%/yr | 0.10.7× | 0% | 150 in 2030+0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 111 | 4,758−1.7%/yr | −1.7%/yr | 4.60.9× | 25% | 4,870 in 2030+0.4%/yr |
| BPH procedures | 64 | 4,475+1.2%/yr | +1.2%/yr | 4.30.8× | 32% | 3,890 in 2030−2.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 31 | 2,534−2.5%/yr | −2.5%/yr | 2.61.0× | 15% | 2,790 in 2030+1.6%/yr |
| Incontinence, prolapse & sacral neuromodulation | 31 | 2,058−0.5%/yr | −0.5%/yr | 2.00.7× | 11% | 2,110 in 2030+0.4%/yr |
| Prostatectomy & nephrectomy | 21 | 948−2%/yr | −2%/yr | 1.00.8× | 0% | 1,120 in 2030+2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 23 | 2,887−4.8%/yr | −4.8%/yr | 2.80.5× | 80% | 2,650 in 2030−1.4%/yr |
| Ear tubes & middle ear surgery | 3 | 291−2.9%/yr | −2.9%/yr | 0.30.8× | 60% | 280 in 2030−0.5%/yr |
| Sleep apnea & airway implants | 4 | 141+51%/yr | +51%/yr | 0.10.5× | 11% | 190 in 2030+5.4%/yr |
| Cochlear implants | 3 | 115+6.7%/yr | +6.7%/yr | 0.10.6× | 0% | 150 in 2030+4.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 130 | 7,399−0.8%/yr | −0.8%/yr | 7.41.1× | 20% | 9,210 in 2030+3.7%/yr |
| Tumor & fibroid embolization | 12 | 902+21%/yr | +21%/yr | 0.91.6× | 55% | 2,310 in 2030+17%/yr |
| Tumor ablation | 1 | 278+2.6%/yr | +2.6%/yr | 0.30.8× | 0% | 470 in 2030+9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 186 | 25,175+32%/yr | +32%/yr | 23.70.8× | 75% | 49,200 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 89 | 5,169−2.2%/yr | −2.2%/yr | 5.10.9× | 6% | 5,360 in 2030+0.6%/yr |
| EP ablation | 75 | 5,013+9.4%/yr | +9.4%/yr | 4.21.2× | 0% | 9,220 in 2030+11%/yr |
| LAA occlusion & loop recorders | 85 | 3,380+18%/yr | +18%/yr | 2.90.8× | 19% | 6,100 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 130 | 5,552−4.5%/yr | −4.5%/yr | 4.60.7× | 1% | 6,460 in 2030+2.6%/yr |
| Structural heart (TAVR, TEER) | 70 | 2,001+4.7%/yr | +4.7%/yr | 1.71.1× | 0% | 2,460 in 2030+3.5%/yr |
| Mechanical circulatory support | 1 | 392−3.6%/yr | −3.6%/yr | 0.40.6× | 0% | 450 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 21 | 418−0.3%/yr | −0.3%/yr | 0.40.9× | 0% | 480 in 2030+2.5%/yr |
| Aneurysm & intracranial embolization | 11 | 407+13%/yr | +13%/yr | 0.40.9× | 0% | 670 in 2030+8.8%/yr |
| DBS & VNS | 5 | 275−0.4%/yr | −0.4%/yr | 0.30.8× | 0% | 420 in 2030+7.4%/yr |
| CSF shunts | 3 | 129−7.5%/yr | −7.5%/yr | 0.10.6× | 0% | 170 in 2030+4.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 225 | 73,424+1%/yr | +1%/yr | 69.11.2× | 87% | 82,800 in 2030+2%/yr |
| Vitreoretinal surgery | 28 | 1,985−3.8%/yr | −3.8%/yr | 1.90.7× | 77% | 2,080 in 2030+0.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 455 | 110,688−2.7%/yr | −2.7%/yr | 108.80.9× | 34% | 119,700 in 2030+1.3%/yr |
| ERCP & endoscopic ultrasound | 48 | 3,175+1.2%/yr | +1.2%/yr | 3.10.9× | 0% | 3,690 in 2030+2.6%/yr |
| Bronchoscopy & lung nodule | 42 | 2,548+1.9%/yr | +1.9%/yr | 2.50.7× | 0% | 4,620 in 2030+10%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.